EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Unbalanced circulating Humanin levels and cardiovascular risk in chronic hemodialysis patients: a pilot, prospective study

Davide Bolignano iD, Marta Greco, Pierangela Presta, Anila Duni, Mariateresa Zicarelli, Simone Mercuri, Efthymios Pappas, Lampros Lakkas, Michela Musolino, Katerina K Naka, Sara Pugliese, Roberta Misiti und 4 weitere

Journal of Nephrology · 2024

DOI: 10.1007/s40620-024-02032-4 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Nephrology, 2024. Verfasst von Davide Bolignano und 15 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Dialysis Unit, Magna Graecia University, Catanzaro, Italy. davide.bolignano@gmail.com. Hauptthemen laut MEDLINE: Renal Dialysis, Kidney Failure, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli studi "Magna Graecia" di Catanzaro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mortality and cardiovascular (CV) risk prediction in individuals with end-stage kidney disease (ESKD) on chronic hemodialysis (HD) remains challenging due to the multitude of implicated factors. In a multicenter ESKD-HD cohort, we tested the prognostic yield of the assessment of circulating Humanin, a small mitochondrial-derived peptide involved in CV protection, on CV events and mortality.

Methods

We conducted a prospective, observational, pilot study on 94 prevalent HD patients. The prognostic capacity of circulating Humanin levels was tested on a primary composite (all-cause mortality + non-fatal CV events) and a secondary exploratory endpoint (all-cause mortality alone).

Results

Baseline Humanin level was comparable in patients reaching the primary or secondary endpoint as compared to others ( p = 0.69 and 0.76, respectively). Unadjusted followed by multivariable Cox regression analyses adjusted for age, left ventricular mass index (LVMi), E / e ’, pulse pressure and diabetes mellitus indicated a non-linear relationship between Humanin levels and the composite outcome with the highest Hazard Ratio (HR) associated with very low (< 450.7 pg/mL; HR ranging from 4.25 to 2.49) and very high (> 759.5 pg/mL; HR ranging from 5.84 to 4.50) Humanin values. Restricted cubic splines fitting univariate and multivariate Cox regression analyses visually confirmed a curvilinear trend with an increasing risk observed for lower and higher Humanin values around the median, respectively. A similar, u-shaped association was also evidenced with the secondary endpoint.

Conclusions

Altered Humanin levels may impart prognostic information in ESKD-HD patients at risk of death or CV events. Future investigations are needed to confirm whether Humanin measurement could improve CV and mortality risk prediction beyond traditional risk models. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisKidney Failure, ChronicCardiovascular DiseasesHumansProspective StudiesPilot ProjectsMaleFemaleMiddle AgedAgedHeart Disease Risk FactorsRisk AssessmentBiomarkersPrognosisIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

BiomarkerCardiovascular riskEnd-stage kidney diseaseHemodialysisHumanin

Substanzen

humaninBiomarkersIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Nephrology and Dialysis Unit, Magna Graecia University, Catanzaro, Italy. davide.bolignano@gmail.com.
  • Department of Medical and Surgical Sciences-Renal Unit, University "Magna Graecia", Campus Salvatore Venuta, Viale Europa, 88100, Catanzaro, Italy. davide.bolignano@gmail.com.
  • Department of Health Sciences, Magna Graecia University, Catanzaro, Italy.
  • Clinical Pathology Lab, Magna Graecia University, Catanzaro, Italy.
  • Nephrology and Dialysis Unit, Magna Graecia University, Catanzaro, Italy.
  • Department of Nephrology, School of Medicine, University of Ioannina, Ioannina, Greece.

ORCID-Profile: Davide Bolignano

Förderung

  • Università degli studi "Magna Graecia" di Catanzaro

Zitieren

APA

Bolignano, D., Greco, M., Presta, P., Duni, A., Zicarelli, M., Mercuri, S., Pappas, E., Lakkas, L., Musolino, M., Naka, K. K., Pugliese, S., Misiti, R., Foti, D. P., Andreucci, M., Coppolino, G., & Dounousi, E. (2024). Unbalanced circulating Humanin levels and cardiovascular risk in chronic hemodialysis patients: a pilot, prospective study. Journal of Nephrology. https://doi.org/10.1007/s40620-024-02032-4

Vancouver

Bolignano D, Greco M, Presta P, Duni A, Zicarelli M, Mercuri S, et al. Unbalanced circulating Humanin levels and cardiovascular risk in chronic hemodialysis patients: a pilot, prospective study. Journal of Nephrology. 2024. doi:10.1007/s40620-024-02032-4

BibTeX
@article{Bolignano2024,
  author = {Bolignano, Davide and Greco, Marta and Presta, Pierangela and Duni, Anila and Zicarelli, Mariateresa and Mercuri, Simone and Pappas, Efthymios and Lakkas, Lampros and Musolino, Michela and Naka, Katerina K and Pugliese, Sara and Misiti, Roberta and Foti, Daniela Patrizia and Andreucci, Michele and Coppolino, Giuseppe and Dounousi, Evangelia},
  title = {Unbalanced circulating Humanin levels and cardiovascular risk in chronic hemodialysis patients: a pilot, prospective study},
  journal = {Journal of Nephrology},
  year = {2024},
  doi = {10.1007/s40620-024-02032-4}
}
Kostenlos starten →